Stock DXCM DEXCOM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

DexCom, Inc.

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
134.6 USD -1.16% Intraday chart for DexCom, Inc. -3.84% +8.44%
Apr. 15 BTIG Adjusts DexCom's Price Target to $156 From $150 MT
Apr. 10 UBS Raises DexCom's Price Target to $163 From $153, Maintains Buy Rating MT

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about DexCom, Inc.

BTIG Adjusts DexCom's Price Target to $156 From $150 MT
UBS Raises DexCom's Price Target to $163 From $153, Maintains Buy Rating MT
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with Its Remote Care Management Platform CI
Citigroup Raises Price Target on DexCom to $161 From $148, Keeps Buy Rating MT
Dexcom Insider Sold Shares Worth $367,472, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $579,180, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $10,802,803, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $2,715,006, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $1,567,363, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $1,182,680, According to a Recent SEC Filing MT
DexCom Initiated at Outperform by RBC, Price Target Set at $165 on View for Revenue Upside Amid Rapidly Expanding Market MT
DexCom is still in the running Our Logo
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care Stocks Advance Wednesday Afternoon MT
DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance MT
US FDA clears use of first over-the-counter continuous glucose monitor RE
DexCom Says Prescription-Free Glucose Biosensor Wins FDA Clearance MT
US FDA clears use of first over-the-counter continuous glucose monitor RE
DexCom, Inc. Announces the FDA Clears Stelo by Dexcom ? the First Glucose Biosensor CI
DexCom Says Use of Automated Insulin Delivery System Reduces Hypoglycemia in Diabetes Patients MT
Transcript : DexCom, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 08:40 AM
DexCom, Inc. Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes with New Data at ATTD CI
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Our Logo
UBS Adjusts DexCom Price Target to $153 From $149, Maintains Buy Rating MT
This time it's for real Our Logo

Chart DexCom, Inc.

Chart DexCom, Inc.
More charts

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-04-24 - Q1 2024 Earnings Release
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for DexCom, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
134.6 USD
Average target price
149 USD
Spread / Average Target
+10.75%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
DEXCOM, INC. Stock DexCom, Inc.
+8.44% 51.87B
ABBOTT LABORATORIES Stock Abbott Laboratories
-1.07% 189B
MEDTRONIC PLC Stock Medtronic plc
-2.61% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.74% 67.81B
CENCORA, INC. Stock Cencora, Inc.
+14.04% 46.67B
HOYA CORPORATION Stock Hoya Corporation
-0.77% 38.68B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+7.58% 27.73B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.52% 26.6B
SARTORIUS STEDIM BIOTECH Stock Sartorius Stedim Biotech
+4.93% 26.34B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
+1.89% 25.48B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. DXCM Stock
  4. News DexCom, Inc.
  5. Insider Sell: Dexcom